Tag: drug development

AI, ML and Automation Use-Cases That Unlock Value in Adaptive & Platform Trials in R&D Amid the rapidly evolving landscape of clinical research, the integration of Artificial Intelligence (AI), Machine Learning (ML), and automation into pharmaceutical R&D is proving to be revolutionary. This comprehensive guide addresses significant use-cases that harness these technologies, particularly focusing on…

Read More “AI, ML and Automation Use-Cases That Unlock Value in Adaptive & Platform Trials in R&D” »

Risk Management and Stage-Gate Governance for Adaptive & Platform Trials in R&D Risk Management and Stage-Gate Governance for Adaptive & Platform Trials in R&D In the landscape of modern clinical research, the demand for efficiency and effectiveness in drug development has ushered in the practice of adaptive and platform trials. These methodologies allow researchers to…

Read More “Risk Management and Stage-Gate Governance for Adaptive & Platform Trials in R&D” »

IP, Exclusivity and Deal-Making Implications of Strong Adaptive & Platform Trials in R&D As the landscape of pharmaceutical research and development (R&D) continues to evolve, the implementation of innovative methodologies such as adaptive and platform trials has significantly influenced the operational and regulatory frameworks of clinical trials. These trial designs not only provide a unique…

Read More “IP, Exclusivity and Deal-Making Implications of Strong Adaptive & Platform Trials in R&D” »

Sustainability, ESG and Green R&D Considerations in Adaptive & Platform Trials in R&D Introduction to Sustainability in Clinical Trials In recent years, the focus on sustainability and Environmental, Social, and Governance (ESG) aspects has gained momentum across various industries, including pharmaceutical research and development (R&D). This shift is not just a trend; it reflects a…

Read More “Sustainability, ESG and Green R&D Considerations in Adaptive & Platform Trials in R&D” »

Roadmap: 12–24 Month Plan to Upgrade Your Organization’s Adaptive & Platform Trials in R&D In the ever-evolving landscape of pharmaceutical research, the demand for efficient and impactful clinical trial methodologies is greater than ever. Adaptive and platform trials have emerged as pivotal frameworks, allowing clinical development to be agile, responsive to real-time data, and more…

Read More “Roadmap: 12–24 Month Plan to Upgrade Your Organization’s Adaptive & Platform Trials in R&D” »

How Adaptive & Platform Trials in R&D Supports Precision Medicine and Biomarker-Driven Trials How Adaptive & Platform Trials in R&D Supports Precision Medicine and Biomarker-Driven Trials In the evolving landscape of pharmaceutical research and development (R&D), adaptive and platform trials have emerged as pivotal methodologies, particularly in the context of precision medicine and biomarker-driven studies….

Read More “How Adaptive & Platform Trials in R&D Supports Precision Medicine and Biomarker-Driven Trials” »

Emerging Science and Technology Trends Redefining Adaptive & Platform Trials in R&D Emerging Science and Technology Trends Redefining Adaptive & Platform Trials in R&D The landscape of clinical trials is evolving rapidly, influenced by technological advancements and a deeper understanding of complex diseases. This evolution is notably present in the implementation of adaptive and platform…

Read More “Emerging Science and Technology Trends Redefining Adaptive & Platform Trials in R&D” »

Talent, Skills and Operating Models Needed to Deliver on Adaptive & Platform Trials in R&D Talent, Skills and Operating Models Needed to Deliver on Adaptive & Platform Trials in R&D In the dynamic landscape of clinical research, the implementation of adaptive and platform trials represents a pivotal evolution in delivering emerging therapies. These methodologies, by…

Read More “Talent, Skills and Operating Models Needed to Deliver on Adaptive & Platform Trials in R&D” »